Ventus Therapeutics
Small Molecules targeting proteins in the inflammasome and nucleic acid sensing signaling pathways
3
Funding Rounds
$300.0m
Money raised
Funding
Funding series
Funding Series Analysis
The company Ventus Therapeutics has raised a total of $300m in funding over 3 rounds.
Key Insights:
- Ventus Therapeutics Series C round, February 2022: $140m
- Ventus Therapeutics Series B round, April 2021: $100m
- Ventus Therapeutics Series A round, May 2020: $60m
Ventus Therapeutics Series C round, February 2022
$140m
Ventus Therapeutics Series B round, April 2021
$100m
Ventus Therapeutics Series A round, May 2020
$60m
Industries
Ventus Therapeutics is active in the following industries: